DENND4B Antibodies

Santa Cruz Biotechnology features a diverse variety of DENND4B monoclonal antibodies for investigating DENND4B's role in cellular processes. DENND4B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DENND4B, a member of the DENN (differentially expressed in normal and neoplastic cells) family, plays a crucial role in regulating intracellular signaling pathways and membrane trafficking. DENND4B is involved in the activation of small GTPases, which are essential for various cellular functions, including cytoskeletal organization and vesicle transport. Research has shown that DENND4B expression levels can vary significantly across different tissue types and developmental stages. Scientists have identified several key domains within DENND4B that contribute to its regulatory functions. Understanding DENND4B function is vital for elucidating its implications in diseases such as cancer and neurodegenerative disorders. DENND4B research continues to reveal new insights into cellular trafficking mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of DENND4B's role in health and disease.